Free delivery nationwide for orders above ₱800

RXDRUG-DRP-8994-02-1pc

NEOCLAZZ MR Gliclazide 60mg Modified-Release Tablet 1's

Selling for 1050
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications

Diabetes mellitus

Administration

Administer with meals.

Contraindications

Hypersensitivity to gliclazide, other sulfonylureas or sulfonamides, or any component of the formulation. Refer to manufacturer labeling for further detail.

Common side-effects

Hypoglycemia, Indigestion, Upset stomach, Headache, Viral infection, Bronchitis, Rhinitis, Back pain

MedsGo Class

Antidiabetic Agents

Features

Dosage
60 mg
Ingredients
  • Gliclazide
Packaging
Modified-Release Tablet 1's
Generic Name
Gliclazide
Registration Number
DRP-8994-02
Classification
Prescription Drug (RX)
Find similar

Product Questions

Questions